Eve & Co Incorporated concludes agreement to export medical cannabis to Germany
Eve & Co Incorporated (TSXV: EVE) (OTCQX: EEVVF) seeks to export dried cannabis flowers to Germany under an agreement with Cannamedical Pharma GmbH.
As part of its strategy to provide medical cannabis to European consumers, Ontario-based Strathroy has entered into an agreement for the supply and purchase of medical cannabis with another German company.
The agreement between the subsidiary of Eve & Co Natural MedCo Ltd. and Cannamedical links an import / export and distribution company of parapharmaceutical, medicinal and narcotic products based in Cologne distribute medical grade cannabis products in Germany.
Melinda Rombouts, CEO of Eve & Co, said they expected the partnership to translate into “a potential supply of up to around $ 7 million in cannabis products over the next two years.”
“CM is committed to improving the quality of life for patients, and as this parallels our guideline, we are delighted to assist CM in this goal,” explained Rombouts. “This agreement is one of ten supply agreements we have with buyers in Germany and is part of our strategy to provide a significant supply in the EU.”
Last week, Natural MedCo launched the collaboration with Adjupharm GmbH, also importer, exporter and distributor of parapharmaceutical, medicinal and narcotic products.
Based in Bad Oldesloe, Germany, Adjupharm is expected to order up to 660 kilograms of dried and gamma-irradiated cannabis flowers from NMC as part of the initial three-year cannabis supply agreement.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.